maximum
[용어속성] Term
Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study
Observational Study
[키워드] acute respiratory distress
Admission
analyzed
Antithrombin
ARDS
C-reactive protein
Coagulation
coagulation parameter
Conventional
Coronavirus disease-19
COVID-19
COVID-19 disease
COVID-19-associated ARDS
Critically ill
Cutoff
D-dimer
Fresh
fresh frozen plasma
Hypercoagulopathy
Impact
IMPROVE
Inflammation
inflammatory parameter
intravascular coagulation
laboratory-confirmed
Level
lowest
material
maximum
Mortality
mortality risk factors
nonsurvivor
organ dysfunction
Organ failure
outcome
outcomes
Patient
patients
plasma
procalcitonin
profile
Prognostic marker
Prognostic value
reported
significantly lower
survival
survivor
syndrome
therapy
Thrombosis prophylaxis
treated
Treatment
value
were recorded
[DOI] 10.4274/tjh.galenos.2021.2020.0695 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.4274/tjh.galenos.2021.2020.0695 PMC 바로가기 [Article Type] Observational Study
Fatality and risk features for prognosis in COVID-19 according to the care approach – a retrospective cohort study
Research Article
[키워드] 95%CI
age
all-cause mortality
analyzed
approach
BNP
Care
Charlson index
Clinical management
Cohort
cohort study
COVID-19
died
effort
Factor
fatality
Fatality rate
feature
Hospitalized
IMV
Invasive mechanical ventilation
Logistic regression
lymphocyte
males
maximum
median age
Mortality
Odds ratio
outcome
Patient
patients hospitalized
Pneumonia
Prognosis
provided
Result
retrospective cohort study
risk
risk factor
Risk factors
Spain
therapeutic
was used
[DOI] 10.1371/journal.pone.0248869 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0248869 PMC 바로가기 [Article Type] Research Article
Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India
인도의 611개 신종 코로나바이러스(SARS-CoV-2) 게놈의 계통-지리 네트워크 및 하플로그룹 분석
Research Article
[키워드] A2a
accession number
Analysis
analyzed
appear
China
clade
country
Epidemic
full-length genome
Genome
GISAID initiative
had more
haplogroup
India
Lineage
maximum
NC_045512.2
NCBI
network
Novel coronavirus
observation
observations
pandemic
pangolin
predominant
prevalent lineage
reference sequence
remaining
Repository
SARS-CoV-2
SARS-CoV-2 genome
SARS-CoV-2 genomes
sequence
Viral
viral evolution
Wuhan
[DOI] 10.26508/lsa.202000925 PMC 바로가기 [Article Type] Research Article
[DOI] 10.26508/lsa.202000925 PMC 바로가기 [Article Type] Research Article
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HA 2 T 2 COVID-19 Mortality Risk Score
COVID-19로 입원한 환자의 트로포닌 및 기타 바이오마커 수준 및 결과: HA 2 T 2 COVID-19 사망률 위험 점수 도출 및 검증
Observational Study
[키워드] 30-Day mortality
adjusted odds ratio
age
Area
Biomarker
Biomarkers
C-reactive protein
characteristic
Cohort
conducted
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID‐19
D-dimer
derivation
develop
dimer
Elevation
ferritin
hypoxia
in-hospital mortality
independent
Level
Logistic regression
maximum
men
Mortality
mortality risk
multivariable logistic regression
Observational cohort study
Other
Patient
patient cohort
patients hospitalized
patients with COVID-19
peptide
primary end point
Prognostic value
receiver
receiver operating characteristic
Result
risk
score
tested
troponin
troponin level
Troponin-I
validation
validation cohort
was performed
was used
were recorded
with COVID-19
[DOI] 10.1161/JAHA.120.018477 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1161/JAHA.120.018477 PMC 바로가기 [Article Type] Observational Study
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2
HIV 감염자의 COVID-19: SARS-CoV-2에 대한 면역 반응 역학의 임상적 의미
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Admission
antiretroviral drugs
Antiretroviral therapy
CD4+
Cellular immune response
clinical
clinical picture
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cytokine
Cytokines
disease severity
dysregulation
elicited
Evidence
evidence of
FIVE
greater
highest
HIV
HIV infection
HIV patients
immune activation
immune response
Immunoglobulin
Immunoglobulin G
immunological
Immunosuppression
implication
increased risk
Inflammatory
maximum
Mild
Nasopharyngeal swab
nasopharyngeal swabs
Neutralizing antibodies
neutralizing antibody
occurred
on admission
Patient
patients
PLWH
Pneumonia
Proinflammatory cytokine
proinflammatory cytokines
protective role
reported
respiratory
Respiratory failure
RNA
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severity of COVID-19
T-cell activation
two patients
Viral
viral clearance
with COVID-19
with HIV
[DOI] 10.1002/jmv.26556 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/jmv.26556 PMC 바로가기 [Article Type] Article
COVID-19 incidence and mortality in Nigeria: gender based analysis
Health Policy
[키워드] Analysis
ARIMA
average
Bayesian information criterion
COVID-19
COVID-19 case
COVID-19 incidence
Daily
Daily incidence
Daily mortality
death case
develop
distribution
Evidence
female
finding
fold
Gender
highlight
incidence
linear
male
maximum
Mortality
Nigeria
P -value
pandemic
Predictive
random
Result
risk
Risk factors
significantly higher
VARMA
white
Wilcoxon signed-rank test
[DOI] 10.7717/peerj.10613 PMC 바로가기 [Article Type] Health Policy
[DOI] 10.7717/peerj.10613 PMC 바로가기 [Article Type] Health Policy
The evolutionary dynamics of endemic human coronaviruses
Rapid Communication
[키워드] accumulated
acute respiratory syndrome
adaptive
Affect
amino acid change
analyzed
antigenic
antigenic variant
average
Bayesian
Bayesian framework
Cell
changes in
coronavirus
Coronavirus-2
dataset
Endemic
endemic human coronavirus
Evidence
Evolution
evolutionary dynamics
Evolutionary rate
expected
gene regions
Genes
genetic variability
glycoprotein
H3N2
HCoV-229E
HCoV-OC43
highest
Host
HPD
human coronavirus
human coronaviruses
human pathogen
IAV
influenza A virus
influenza vaccines
less
likelihood
maximum
mutations
neutralizing antibody responses
Non-synonymous mutation
occurred
pandemic
Phylogeny
Positive selection
protective immunity
RBD
Receptor binding domain
representing
reservoir
RNA virus
S gene
SARS-CoV-2
SARS-CoV-2 evolution
similarities
similarity
stability
Substitution
supported
target
the RBD
Vaccine
viral entry
virus
[DOI] 10.1093/ve/veab020 PMC 바로가기 [Article Type] Rapid Communication
[DOI] 10.1093/ve/veab020 PMC 바로가기 [Article Type] Rapid Communication
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
COVID-19 폐렴 환자에서 호흡 악화 예방을 위한 BIO101의 효능 및 안전성 테스트(COVA 연구): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
20-hydroxyecdysone
absence
accumulation
ACE2
Activation
acute respiratory distress
acute respiratory distress syndrome
adaptive
addition
administration
Airway Pressure
all-cause mortality
ALT
Alter
amenorrhea
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin converting enzyme-2
Anti-inflammatory
anticipated
approved
ARDS
arterial oxygen saturation
AST
Asymptomatic
balance
baseline
being
Belgium
beneficiary
Bilirubin
BIO101
Biomarker
Biomarkers
birth control
blinded
Brazil
breath
Cardiomyopathy
Care
Caregivers
caused
clinical development
Clinical finding
Clinical findings
clinical picture
co-morbidities
co-morbidity
collected
Compliance
condition
condom
conducted
confirmation
Consumption
Continuous
Continuous Positive Airway Pressure
Contraception
contraceptive method
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infection symptom
COVID-19 infection symptoms
COVID-19 patient
COVID-19 patients
criteria
criterion
daily dose
Day
death
defined
Department
Deterioration
develop
diabetes
diagnosis of COVID-19
dialysis
discharge
discharged
disease
dissemination
DMC
dose
double-blind
downstream
ECMO
Effect
effective
Efficacy
Efficacy and safety
EGFR
element
eligible participant
Eligible participants
endotracheal tube
Endpoint
enzyme
etonogestrel
EudraCT
European
evaluate
event
Evidence
evidence of
exclusion criteria
expected
exploratory
extracorporeal membrane oxygenation
female
female participants
Final
FiO2
Flow
following
form
France
French
functional
Gault
Gender
healthcare
healthcare facility
heart disease
High-flow oxygen
higher risk
hospital
hospital care
Hospitalization
Hospitalized
hypersensitivity
hypertension
IBM
ICF
Imbalance
include
Inclusion
independent
indication
Infection
Inflammation
informed consent form
injection
Interim analyses
interim analysis
Intervention
intrauterine device
Intubated
Invasive mechanical ventilation
IWRS system
lactating
limit
Liver function
liver function tests
male participants
marker
Mas receptor
maximum
measure
mechanical ventilation
medical intervention
medication
medications
minute
moderate
morbidities
Moribund
Mortality
mouth
Multiorgan dysfunction
muscles
myocarditis
negative urine pregnancy test
Non-COVID-19
number
obesity
objective
observation
offer
Older
oral contraceptive
outcome
outlined
oxygen
Part
participant
partner
pathway
Pathways
patients with COVID-19
patients with SARS-CoV-2
PCR
performed
Pericarditis
Physical examination
Placebo
placebo-controlled
Pneumonia
positive airway pressure
post-intervention
post-menopausal
powder
pregnancy test
pressure
primary endpoint
proof
proportion
Proportion of participant
protocol
public health
randomised
randomised controlled trial
randomization
RAS
reached
receive
receiving
receptor
recruited
recruitment
Registered
renal
renal disease
renal insufficiency
Renin
renin angiotensin system
renin-angiotensin system
reproduction
required
resource
respiratory
Respiratory distress syndrome
Respiratory failure
Respiratory function
respiratory symptoms
restored
risk
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 spike protein
second
secondary
secondary endpoint
security
severe pneumonia
Shock
Social Security
specimen
Sperm
Spike protein
SpO2
Statistical power
status
Sterilization
Stratification
stratified
study medication
Study protocol
supplementary material
survival
suspicion
Symptom
syndrome
tachypnea
target population
tested
Testing
the primary endpoint
therapeutic
therapeutic option
tissue
Tolerability
Total
total bilirubin
Treatment
treatment arm
treatment period
Triage
Trial
Trial registration
ULN
Urine
USA
variety
vasectomy
Version
Viral load
water
website
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
Ozone potential to fight against SAR-COV-2 pandemic: facts and research needs
Research Article
Published on
Journal: Environmental science and pollution research inter [Category] COVID-19, MERS, SARS,
Journal: Environmental science and pollution research inter [Category] COVID-19, MERS, SARS,
[키워드] accumulating
air and surface
ambient
analyzed
antiviral activity
can be used
carried
Concentration
condition
Contact
coronavirus
COVID-19
COVID-19 pandemic
develop
Disinfections
dosage
dosages
effective
equipment
evaluate
Evidence
fatty
Heat & liquid sensitive materials
inefficient
maximum
ozone gas
Protective
protocol
Radiation
reduce
reducing
required
Research
Safe
SARS-CoV-2
significantly
social distancing
the SARS-CoV-2
the SARS-CoV-2 virus
These data
Treatment
ultraviolet
ultraviolet light
Vaccine
Viral load
viral strains
virus
virus load
Volume
[DOI] 10.1007/s11356-020-12036-9 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1007/s11356-020-12036-9 PMC 바로가기 [Article Type] Research Article